Pantazopoulos Helen, Diop Mame-Kany, Grosset Andrée-Anne, Rouleau-Gagné Frédérique, Al-Saleh Afnan, Boblea Teodora, Trudel Dominique
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), 900 Saint-Denis, Montreal, QC H2X 0A9, Canada.
Institut du Cancer de Montréal, 900 Saint-Denis, Montreal, QC H2X 0A9, Canada.
Cancers (Basel). 2022 Feb 6;14(3):820. doi: 10.3390/cancers14030820.
Intraductal carcinoma of the prostate (IDC-P) is one of the most aggressive types of prostate cancer (PCa). IDC-P is identified in approximately 20% of PCa patients and is associated with recurrence, metastasis, and PCa-specific death. The main feature of this histological variant is the colonization of benign glands by PCa cells. Although IDC-P is a well-recognized independent parameter for metastasis, mechanisms by which IDC-P cells can spread and colonize other tissues are not fully known. In this review, we discuss the molecular portraits of IDC-P determined by immunohistochemistry and genomic approaches and highlight the areas in which more research is needed.
前列腺导管内癌(IDC-P)是前列腺癌(PCa)中侵袭性最强的类型之一。约20%的PCa患者中可发现IDC-P,其与复发、转移及PCa特异性死亡相关。这种组织学变异型的主要特征是癌细胞对良性腺管的浸润。尽管IDC-P是一个公认的转移独立参数,但IDC-P细胞能够扩散并在其他组织中定植的机制尚不完全清楚。在本综述中,我们讨论了通过免疫组织化学和基因组学方法确定的IDC-P分子特征,并强调了需要更多研究的领域。